PDX-: Demonstration of oncogenic properties in pancreatic cancer

Cancer

Volumn 117, Issue 4, 2011, Pages 723-733

  Liu, Shi He ^a   Patel, Sanjeet ^a   Gingras, Marie Claude ^a   Nemunaitis, John ^b   Zhou, Guisheng ^a   Chen, Changyi ^a   Li, Min ^a   Fisher, William ^a   Gibbs, Richard ^a   Brunicardi, F Charles ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Mary Crowley Cancer Research Centers   (United States)

Author keywords

invasion; microarray; oncogene; pancreatic cancer; PDX 1; proliferation; transcription factor; transformation

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN E; PROTEIN P21; PROTEIN P27; PROTEIN P53; TRANSCRIPTION FACTOR PDX 1; SHORT HAIRPIN RNA; HOMEODOMAIN PROTEIN; INSULIN PROMOTER FACTOR 1; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; CELL STRAIN HEK293; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; ONCOGENE; PANCREAS CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR GROWTH; UPREGULATION; ANIMAL MODEL; CELL CYCLE; GENE FUNCTION; HEK293 CELL LINE; IN VITRO STUDY; IN VIVO STUDY; PANCREAS CANCER; PANCREATIC CANCER CELL LINE; PDX 1 GENE; ANIMAL; CANCER TRANSPLANTATION; GENETIC TRANSFECTION; GENETICS; MOUSE MUTANT; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; HEK293 CELLS; HOMEODOMAIN PROTEINS; HUMANS; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; ONCOGENES; PANCREATIC NEOPLASMS; RNA, SMALL INTERFERING; TRANS-ACTIVATORS; TRANSFECTION; UP-REGULATION;

EID: 79551691442     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25629     Document Type: Article

References (57)

1. Deramaudt T, Rustgi AK., Mutant KRAS in the initiation of pancreatic cancer. Biochim Biophys Acta. 2005; 1756: 97-101.
2. Hingorani SR, Wang L, Multani AS, et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell. 2005; 7: 469-483.
3. Tian X, Chakrabarti A, Amirkhanov NV, et al. External imaging of CCND1, MYC, and KRAS oncogene mRNAs with tumor-targeted radionuclide-PNA-peptide chimeras. Ann N Y Acad Sci. 2005; 1059: 106-144.
4. Naka T, Kobayashi M, Ashida K, Toyota N, Kaneko T, Kaibara N., Aberrant p16INK4 expression related to clinical stage and prognosis in patients with pancreatic cancer. Int J Oncol. 1998; 12: 1111-1116.
5. Pasca di Magliano M, Biankin AV, Heiser PW, et al. Common activation of canonical Wnt signaling in pancreatic adenocarcinoma. PLoS One. 2007; 2: e1155.
6. Heiser PW, Cano DA, Landsman L, et al. Stabilization of beta-catenin induces pancreas tumor formation. Gastroenterology. 2008; 135: 1288-1300.
7. Truty MJ, Urrutia R., Basics of TGF-beta and pancreatic cancer. Pancreatology. 2007; 7: 423-435.
8. Katoh M., Transcriptional mechanisms of WNT5A based on NF-kappaB, Hedgehog, TGFbeta, and Notch signaling cascades. Int J Mol Med. 2009; 23: 763-769.
9. Miyamoto Y, Maitra A, Ghosh B, et al. Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell. 2003; 3: 565-576.
10. Radtke F, Raj K., The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer. 2003; 3: 756-767.
11. Thayer SP, di Magliano MP, Heiser PW, et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature. 2003; 425: 851-856.
12. Ashizawa S, Brunicardi FC, Wang XP., PDX-1 and the pancreas. Pancreas. 2004; 28: 109-120.
13. Swift GH, Liu Y, Rose SD, et al. An endocrine-exocrine switch in the activity of the pancreatic homeodomain protein PDX1 through formation of a trimeric complex with PBX1b and MRG1 (MEIS2). Mol Cell Biol. 1998; 18: 5109-5120.
14. Beattie GM, Itkin-Ansari P, Cirulli V, et al. Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes. 1999; 48: 1013-1019.
15. Feanny MA, Fagan SP, Ballian N, et al. PDX-1 expression is associated with islet proliferation in vitro and in vivo. J Surg Res. 2008; 144: 8-16.
16. Dutta S, Gannon M, Peers B, Wright C, Bonner-Weir S, Montminy M., PDX:PBX complexes are required for normal proliferation of pancreatic cells during development. Proc Natl Acad Sci U S A. 2001; 98: 1065-1070.
17. Taguchi M, Yamaguchi T, Otsuki M., Induction of PDX-1-positive cells in the main duct during regeneration after acute necrotizing pancreatitis in rats. J Pathol. 2002; 197: 638-646.
18. Liu T, Wang C, Wan C, Xiong J, Xu Y, Zhou F., PDX-1 expression in pancreatic ductal cells after partial pancreatectomy in adult rats. J Huazhong Univ Sci Technolog Med Sci. 2004; 24: 464-466.
19. Du YC, Klimstra DS, Varmus H., Activation of PyMT in beta cells induces irreversible hyperplasia, but oncogene-dependent acinar cell carcinomas when activated in pancreatic progenitors. PLoS One. 2009; 4: e6932.
20. Stanger BZ, Stiles B, Lauwers GY, et al. Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. Cancer Cell. 2005; 8: 185-195.
21. Lewis BC, Klimstra DS, Varmus HE., The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer. Genes Dev. 2003; 17: 3127-3138.
22. Miyatsuka TKH, Shiraiwa T, Matsuoka TA, et al. Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation. Genes Dev. 2006; 20: 1435-1440.
23. Gidekel Friedlander SY, Chu GC, Snyder EL, et al. Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras. Cancer Cell. 2009; 16: 379-389.
24. Ballian N, Liu SH, Brunicardi FC., Transcription factor PDX-1 in human colorectal adenocarcinoma: a potential tumor marker ? World J Gastroenterol. 2008; 14: 5823-5826.
25. Jonmarker S, Glaessgen A, Culp WD, et al. Expression of PDX-1 in prostate cancer, prostatic intraepithelial neoplasia and benign prostatic tissue. APMIS. 2008; 116: 491-498.
26. Koizumi M, Doi R, Toyoda E, et al. Increased PDX-1 expression is associated with outcome in patients with pancreatic cancer. Surgery. 2003; 134: 260-266.
27. Leys CM, Nomura S, Rudzinski E, et al. Expression of Pdx-1 in human gastric metaplasia and gastric adenocarcinoma. Hum Pathol. 2006; 37: 1162-1168.
28. Liu S, Ballian N, Belaguli NS, et al. PDX-1 acts as a potential molecular target for treatment of human pancreatic cancer. Pancreas. 2008; 37: 210-220.
29. Liu T, Gou SM, Wang CY, Wu HS, Xiong JX, Zhou F., Pancreas duodenal homeobox-1 expression and significance in pancreatic cancer. World J Gastroenterol. 2007; 13: 2615-2618.
30. Wang XP, Li ZJ, Magnusson J, Brunicardi FC., Tissue MicroArray analyses of pancreatic duodenal homeobox-1 (PDX-1) in human cancers. World J. Surgery. 2005; 29: 334-338.
31. Wang XP, Li ZJ, Magnusson J, Brunicardi FC., Tissue MicroArray analyses of pancreatic duodenal homeobox-1 in human cancers. World J Surg. 2005; 29: 334-338.
32. Quint K, Stintzing S, Alinger B, et al. The expression pattern of PDX-1, SHH, Patched and Gli-1 is associated with pathological and clinical features in human pancreatic cancer. Pancreatology. 2009; 9: 116-126.
33. Tusher VG, Tibshirani R, Chu G., Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001; 98: 5116-5121.
34. Wu Z, Irizarry RA, Gentleman R, Martinez-Murillo F, Spencer F,. A model based background adjustment for oligonucleotide expression arrays. J Am Stat Assoc. 2004; 99: 909-917.
35. Yokoi N, Serikawa T, Walther R., Pdx-1, a homeodomain transcription factor required for pancreas development, maps to rat chromosome 12. Exp Anim. 1997; 46: 323-324.
36. Stevenson KS, McGlynn L, Hodge M, et al. Isolation, characterization, and differentiation of thy1.1-sorted pancreatic adult progenitor cell populations. Stem Cells Dev. 2009; 18: 1389-1398.
37. Peshavaria M, Cissell MA, Henderson E, Petersen HV, Stein R., The PDX-1 activation domain provides specific functions necessary for transcriptional stimulation in pancreatic beta-cells. Mol Endocrinol. 2000; 14: 1907-1917.
38. Offield MF, Jetton TL, Labosky PA, et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development. 1996; 122: 983-995.
39. Melloul D., Transcription factors in islet development and physiology: role of PDX-1 in beta-cell function. Ann N Y Acad Sci. 2004; 1014: 28-37.
40. McKinnon CM, Docherty K., Pancreatic duodenal homeobox-1, PDX-1, a major regulator of beta cell identity and function. Diabetologia. 2001; 44: 1203-1214.
41. Meivar-Levy I, Sapir T, Gefen-Halevi S, et al. Pancreatic and duodenal homeobox gene 1 induces hepatic dedifferentiation by suppressing the expression of CCAAT/enhancer-binding protein beta. Hepatology. 2007; 46: 898-905.
42. Tuveson DA, Zhu L, Gopinathan A, et al. Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma. Cancer Res. 2006; 66: 242-247.
43. Kojima K, Vickers SM, Adsay NV, et al. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia. Cancer Res. 2007; 67: 8121-8130.
44. Izeradjene K, Combs C, Best M, et al. Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. Cancer Cell. 2007; 11: 229-243.
45. Ma J, Chen M, Wang J, et al. Pancreatic duodenal homeobox-1 (PDX1) functions as a tumor suppressor in gastric cancer. Carcinogenesis. 2008; 29: 1327-1333.
46. Buettner M, Dimmler A, Magener A, et al. Gastric PDX-1 expression in pancreatic metaplasia and endocrine cell hyperplasia in atrophic corpus gastritis. Mod Pathol. 2004; 17: 56-61.
47. Leys CM, Nomura S, Rudzinski E, et al. Expression of PDX-1 in human gastric metaplasia and gastric adenocarcinoma. Hum Pathol. 2006; 37: 1162-1168.
48. Sakai HEY, Li XL, Akiyama Y, et al. PDX-1 homeobox protein expression in pseudopyloric glands and gastric carcinomas. Gut. 2004; 53: 323-330.
49. Srivastava A, Hornick JL., Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors. Am J Surg Pathol. 2009; 33: 626-632.
50. Tingstedt JE, Edlund H, Madsen OD, Larsson LI., Gastric amylin expression. Cellular identity and lack of requirement for the homeobox protein PDX-1. A study in normal and PDX-1-deficient animals with a cautionary note on antiserum evaluation. J Histochem Cytochem. 1999; 47: 973-980.
51. Malik MT, Kakar SS., Regulation of angiogenesis and invasion by human pituitary tumor transforming gene (PTTG) through increased expression and secretion of matrix metalloproteinase-2 (MMP-2). Mol Cancer. 2006; 5: 61.
52. Ouyang H, Mou L, Luk C, et al. Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype. Am J Pathol. 2000; 157: 1623-1631.
53. Campbell PM, Groehler AL, Lee KM, Ouellette MM, Khazak V, Der CJ., K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling. Cancer Res. 2007; 67: 2098-2106.
54. Chao C, Goluszko E, Lee YT, et al. Constitutively active CCK2 receptor splice variant increases Src-dependent HIF-1 alpha expression and tumor growth. Oncogene. 2007; 26: 1013-1019.
55. Rafiq I, da Silva Xavier G, Hooper S, Rutter GA., Glucose-stimulated preproinsulin gene expression and nuclear trans-location of pancreatic duodenum homeobox-1 require activation of phosphatidylinositol 3-kinase but not p38 MAPK/SAPK2. J Biol Chem. 2000; 275: 15977-15984.
56. Watanabe H, Saito H, Nishimura H, Ueda J, Evers BM., Activation of phosphatidylinositol-3 kinase regulates pancreatic duodenal homeobox-1 in duct cells during pancreatic regeneration. Pancreas. 2008; 36: 153-159.
57. Morton JP, Lewis BC., Shh signaling and pancreatic cancer: implications for therapy? Cell Cycle. 2007; 6: 1553-1557.